There is no regulatory oversight of AI, which is a *major* problem.
Compared to AI, progress with Neuralink will be slow and easy to assess, as there is large regulatory apparatus approving medical devices.
— Elon Musk (@elonmusk) December 1, 2022
There is no regulatory oversight of AI, which is a *major* problem. I’ve been calling for AI safety regulation for over a decade!